EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Spatial analysis of microRNA regulation at defined tumor hypoxia levels reveals biological traits of aggressive prostate cancer

Vilde E Skingen iD, Unn Beate Salberg, Tord Hompland, Christina S Fjeldbo, Hanna Helgeland, Kari-Anne M Frikstad, Harald B Ragnum, Ljiljana Vlatkovic, Knut Håkon Hole, Therese Seierstad, Heidi Lyng iD

The Journal of Pathology · 2024

DOI: 10.1002/path.6344 ↗

At a glance

Journal article in The Journal of Pathology, 2024. Written by Vilde E Skingen and 10 co-authors. Institution: Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Major MEDLINE topics: Prostatic Neoplasms, MicroRNAs, Tumor Hypoxia, Gene Expression Regulation, Neoplastic. Cited 2 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The South-Eastern Norway Regional Health Authority, The Norwegian Cancer Society.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Mechanisms regulating the gene expression program at different hypoxia severity levels in patient tumors are not understood. We aimed to determine microRNA (miRNA) regulation of this program at defined hypoxia levels from moderate to severe in prostate cancer. Biopsies from 95 patients were used, where 83 patients received the hypoxia marker pimonidazole before prostatectomy. Forty hypoxia levels were extracted from pimonidazole‐stained histological sections and correlated with miRNA and gene expression profiles determined by RNA sequencing and Illumina bead arrays. This identified miRNAs associated with moderate ( n = 7) and severe ( n = 28) hypoxia and predicted their target genes. The scores of miRNAs or target genes showed prognostic significance, as validated in an external cohort of 417 patients. The target genes showed enrichment of gene sets for cell proliferation and MYC activation at all hypoxia levels and PTEN inactivation at severe hypoxia. This was confirmed by RT‐qPCR for MYC and PTEN , by Ki67 immunohistochemistry, and by gene set analysis in an external cohort. To assess whether miRNA regulation occurred within the predicted hypoxic regions, a method to quantify co‐localization of multiple histopathology parameters at defined hypoxia levels was applied. A high Ki67 proliferation index co‐localized significantly with hypoxia at all levels. The co‐localization index was strongly associated with poor prognosis. Absence of PTEN staining co‐localized significantly with severe hypoxia. The scores for miRNAs correlated with the co‐localization index for Ki67 staining and hypoxia, consistent with miRNA regulation within the overlapping regions. This was confirmed by showing miR‐210‐3p expression within severe hypoxia by in situ hybridization. Cell line experiments (22Rv1, PC3) were conducted to determine whether miRNAs and target genes were regulated directly by hypoxia. Most of them were hypoxia‐unresponsive, and probably regulated by other mechanisms such as MYC activation. In conclusion, in aggressive, hypoxic prostate tumors, cancer cells exhibit different proliferative gene expression programs that is regulated by miRNAs and depend on whether the cells reside in moderate or severe hypoxic regions. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Prostatic NeoplasmsMicroRNAsTumor HypoxiaGene Expression Regulation, NeoplasticHumansMaleCell ProliferationBiomarkers, TumorAgedMiddle AgedProto-Oncogene Proteins c-mycPrognosis

Author keywords

MYCPTENgene expressionhypoxiamiRNApimonidazoleprostate cancerspatial biology

Substances

MicroRNAsBiomarkers, TumorProto-Oncogene Proteins c-myc

Authors and institutions

  • Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Department of Physics, University of Oslo, Oslo, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Department of Hematology and Oncology, Telemark Hospital Trust, Skien, Norway.
  • Department of Pathology, Oslo University Hospital, Oslo, Norway.
  • Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.

ORCID profiles: Vilde E Skingen, Heidi Lyng

Funding

  • The South-Eastern Norway Regional Health Authority
  • The Norwegian Cancer Society

Cite

APA

Skingen, V. E., Salberg, U. B., Hompland, T., Fjeldbo, C. S., Helgeland, H., Frikstad, K. M., Ragnum, H. B., Vlatkovic, L., Hole, K. H., Seierstad, T., & Lyng, H. (2024). Spatial analysis of microRNA regulation at defined tumor hypoxia levels reveals biological traits of aggressive prostate cancer. The Journal of Pathology. https://doi.org/10.1002/path.6344

Vancouver

Skingen VE, Salberg UB, Hompland T, Fjeldbo CS, Helgeland H, Frikstad KM, et al. Spatial analysis of microRNA regulation at defined tumor hypoxia levels reveals biological traits of aggressive prostate cancer. The Journal of Pathology. 2024. doi:10.1002/path.6344

BibTeX
@article{Skingen2024,
  author = {Skingen, Vilde E and Salberg, Unn Beate and Hompland, Tord and Fjeldbo, Christina S and Helgeland, Hanna and Frikstad, Kari-Anne M and Ragnum, Harald B and Vlatkovic, Ljiljana and Hole, Knut Håkon and Seierstad, Therese and Lyng, Heidi},
  title = {Spatial analysis of microRNA regulation at defined tumor hypoxia levels reveals biological traits of aggressive prostate cancer},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6344}
}
Start for free →